Assessment of Lipid Profile in Juvenile Systemic Lupus Erythematosus
1 other identifier
observational
102
1 country
1
Brief Summary
. To determine pattern and frequency of dyslipoproteinemia in patients with newly diagnosed juvenile SLE and to assess effect of disease activity on lipid profile of patients with juvenile SLE.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 13, 2023
CompletedFirst Posted
Study publicly available on registry
November 30, 2023
CompletedStudy Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedNovember 30, 2023
September 1, 2023
1.8 years
November 13, 2023
November 21, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
lipid profile
pattern and frequency of dyslipoproteinemia in patients with newly diagnosed JSLE .
2 years
lipid profile
effect of disease activity on lipid profile of patients with JSLE
2 years
Study Arms (3)
newly diagnosed juvenile systemic lupus erythematosus
old cases of juvenile systemic lupus in activity
old cases of juvenile systemic lupus not in activity(controlled)
Interventions
Measurements for CHOL,TG,LDL-C and HDL-C obtained following an overnight fasting
Eligibility Criteria
.Patients diagnosed with jSLE between 5 and 18 years of age
You may qualify if:
- Patients who are diagnosed according to 2019 European League against Rheumatism (EULAR) /American College of Rheumatology (ACR) SLE classification criteria .
- Patients diagnosed with jSLE between 5 and 18 years of age
You may not qualify if:
- \. Patients on lipid lowering drugs for any other reason. 2. Patients with other autoimmune disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut university
Asyut, Egypt
Related Publications (4)
Sarkissian T, Beyene J, Feldman B, McCrindle B, Silverman ED. Longitudinal examination of lipid profiles in pediatric systemic lupus erythematosus. Arthritis Rheum. 2007 Feb;56(2):631-8. doi: 10.1002/art.22332.
PMID: 17265498BACKGROUNDTyrrell PN, Beyene J, Benseler SM, Sarkissian T, Silverman ED. Predictors of lipid abnormalities in children with new-onset systemic lupus erythematosus. J Rheumatol. 2007 Oct;34(10):2112-9. Epub 2007 Sep 1.
PMID: 17787042BACKGROUNDMachado D, Sarni RO, Abad TT, Silva SG, Khazaal EJ, Hix S, Correia MS, Suano-Souza FI, Len CA, Terreri MT. Lipid profile among girls with systemic lupus erythematosus. Rheumatol Int. 2017 Jan;37(1):43-48. doi: 10.1007/s00296-015-3393-z. Epub 2015 Nov 16.
PMID: 26573664BACKGROUNDRodrigues WDR, Sarni ROS, Abad TTO, Silva SGLD, Souza FIS, Len CA, Terreri MT. Lipid profile of pediatric patients with chronic rheumatic diseases - a retrospective analysis. Rev Assoc Med Bras (1992). 2020 Aug;66(8):1093-1099. doi: 10.1590/1806-9282.66.8.1093.
PMID: 32935804BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jaafar I Mohamad, professor
Assiut University
- PRINCIPAL INVESTIGATOR
Naglaa S Mohamad, lecturer
Assiut University
- PRINCIPAL INVESTIGATOR
Yosra M Mamdouh, lecturer
Assiut University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
November 13, 2023
First Posted
November 30, 2023
Study Start
December 1, 2023
Primary Completion
September 1, 2025
Study Completion
October 1, 2025
Last Updated
November 30, 2023
Record last verified: 2023-09